Westside Investment Management Inc. Lowers Stock Position in

Westside Investment Management Inc. reduced its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 11.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 133,744 shares of the company’s stock after selling 16,865 shares during the quarter. Westside Investment […]

Related Keywords

Markl Baum , Zurcher Kantonalbank Zurich Cantonalbank , Pharmaceuticals Inc , News Ratings For Harrow Health Daily , Harrow Health , Quarter For Harrow Health , Harrow Health Company Profile , Westside Investment Management Inc , Harrow Health Inc , Exchange Commission , Securities Exchange Commission , Nasdaq , Harrow Health Stock , Mendota Financial Group , Insider Activity At Harrow Health , Marshall Wace , Eton Pharmaceuticals Inc , Jump Financial , Surface Ophthalmics Inc , Opaleye Management Inc , Westside Investment Management , Free Report , Investment Management , Financial Group , Opaleye Management , Get Free Report , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Throw , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,